Search research articles
Contact Us
Filters
Showing results (81-90 of 96) with videos related to
Page
of 10
Sort By:
The Lancet. Haematology
|
September 24, 2020
Molecular response after obinutuzumab plus high-dose cytarabine induction for transplant-eligible patients with untreated mantle cell lymphoma (LyMa-101): a phase 2 trial of the LYSA group
Steven Le Gouill, Asma Beldi-Ferchiou, Marion Alcantara, et al.
Human Mutation
|
February 27, 2010
Loss-of-function of MYO5B is the main cause of microvillus inclusion disease: 15 novel mutations and a CaCo-2 RNAi cell model
Frank M Ruemmele, Thomas Müller, Natalia Schiefermeier, et al.
Human Genetics
|
October 22, 2013
Genetic characterization of congenital tufting enteropathy: epcam associated phenotype and involvement of SPINT2 in the syndromic form
Julie Salomon, Olivier Goulet, Danielle Canioni, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 30, 2004
The mutator pathway is a feature of immunodeficiency-related lymphomas
Alex Duval, Martine Raphael, Caroline Brennetot, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 15, 2015
The Prognostic Impact of CD163-Positive Macrophages in Follicular Lymphoma: A Study from the BC Cancer Agency and the Lymphoma Study Association
Robert Kridel, Luc Xerri, Bénédicte Gelas-Dore, et al.
American Journal of Hematology
|
November 25, 2014
Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B-cell non-Hodgkin lymphomas, ANRS HC-13 lympho-C study
Jean-Marie Michot, Danielle Canioni, Henda Driss, et al.
Lancet (London, England)
|
January 11, 2017
Masitinib for treatment of severely symptomatic indolent systemic mastocytosis: a randomised, placebo-controlled, phase 3 study
Olivier Lortholary, Marie Olivia Chandesris, Cristina Bulai Livideanu, et al.
The Journal of Infectious Diseases
|
July 25, 2014
Inherited CARD9 deficiency in 2 unrelated patients with invasive Exophiala infection
Fanny Lanternier, Elisa Barbati, Ulrich Meinzer, et al.
The Journal of Allergy and Clinical Immunology
|
June 20, 2014
Characterization of Crohn disease in X-linked inhibitor of apoptosis-deficient male patients and female symptomatic carriers
Claire Aguilar, Christelle Lenoir, Nathalie Lambert, et al.
Blood
|
October 4, 2013
A Mendelian predisposition to B-cell lymphoma caused by IL-10R deficiency
Bénédicte Neven, Emilie Mamessier, Julie Bruneau, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 96) with videos related to
Sort By:
Page
of 10
The Lancet. Haematology
|
September 24, 2020
Molecular response after obinutuzumab plus high-dose cytarabine induction for transplant-eligible patients with untreated mantle cell lymphoma (LyMa-101): a phase 2 trial of the LYSA group
Steven Le Gouill, Asma Beldi-Ferchiou, Marion Alcantara, et al.
Human Mutation
|
February 27, 2010
Loss-of-function of MYO5B is the main cause of microvillus inclusion disease: 15 novel mutations and a CaCo-2 RNAi cell model
Frank M Ruemmele, Thomas Müller, Natalia Schiefermeier, et al.
Human Genetics
|
October 22, 2013
Genetic characterization of congenital tufting enteropathy: epcam associated phenotype and involvement of SPINT2 in the syndromic form
Julie Salomon, Olivier Goulet, Danielle Canioni, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 30, 2004
The mutator pathway is a feature of immunodeficiency-related lymphomas
Alex Duval, Martine Raphael, Caroline Brennetot, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 15, 2015
The Prognostic Impact of CD163-Positive Macrophages in Follicular Lymphoma: A Study from the BC Cancer Agency and the Lymphoma Study Association
Robert Kridel, Luc Xerri, Bénédicte Gelas-Dore, et al.
American Journal of Hematology
|
November 25, 2014
Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B-cell non-Hodgkin lymphomas, ANRS HC-13 lympho-C study
Jean-Marie Michot, Danielle Canioni, Henda Driss, et al.
Lancet (London, England)
|
January 11, 2017
Masitinib for treatment of severely symptomatic indolent systemic mastocytosis: a randomised, placebo-controlled, phase 3 study
Olivier Lortholary, Marie Olivia Chandesris, Cristina Bulai Livideanu, et al.
The Journal of Infectious Diseases
|
July 25, 2014
Inherited CARD9 deficiency in 2 unrelated patients with invasive Exophiala infection
Fanny Lanternier, Elisa Barbati, Ulrich Meinzer, et al.
The Journal of Allergy and Clinical Immunology
|
June 20, 2014
Characterization of Crohn disease in X-linked inhibitor of apoptosis-deficient male patients and female symptomatic carriers
Claire Aguilar, Christelle Lenoir, Nathalie Lambert, et al.
Blood
|
October 4, 2013
A Mendelian predisposition to B-cell lymphoma caused by IL-10R deficiency
Bénédicte Neven, Emilie Mamessier, Julie Bruneau, et al.
Page
of 10